Description
Description
CJC-1295 (with DAC) is a research-grade peptide analog studied in controlled laboratory environments for its extended interaction with growth hormone–releasing hormone (GHRH) receptor pathways. This version includes the Drug Affinity Complex (DAC) modification, which is designed to prolong peptide stability and receptor engagement within experimental systems. Researchers examine CJC-1295 (with DAC) for its sustained signaling profile and its relevance in comparative endocrine, metabolic, and cellular pathway analysis.
The DAC modification allows for longer persistence in research models, making it useful in studies evaluating prolonged receptor activation, signaling duration, and downstream biochemical effects. Each vial is produced under strict research manufacturing standards and independently batch-tested for identity, purity, and composition to ensure consistent performance in laboratory applications.
Key Research Features
-
Research-grade peptide suitable for controlled laboratory experiments
-
DAC modification designed for extended peptide stability and signaling duration
-
Investigated in studies involving sustained GHRH receptor interaction
-
Independently tested for identity, purity, and composition
-
Sterile, lyophilized powder for precise laboratory handling
Specifications
-
Content: 5mg lyophilized peptide
-
Form: Sterile, freeze-dried powder
-
Storage: Store at −20°C; protect from heat and light
Important Notice
For laboratory research only.
Not for human or animal use.
